# Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention

> **NCT04538534** · PHASE3 · COMPLETED · sponsor: **Pr. Semir Nouira** · enrollment: 1500 (actual)

## Conditions studied

- Spasm Artery

## Interventions

- **DRUG:** Nicardipine

## Key facts

- **NCT ID:** NCT04538534
- **Lead sponsor:** Pr. Semir Nouira
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04538534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04538534, "Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04538534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*